| An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis HW Smith, A Hirukawa, V Sanguin-Gendreau, I Nandi, CR Dufour, D Zuo, ... Nature communications 10 (1), 2901, 2019 | 34 | 2019 |
| Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression I Nandi, HW Smith, V Sanguin-Gendreau, L Ji, A Pacis, V Papavasiliou, ... The Journal of Clinical Investigation 133 (7), 2023 | 20 | 2023 |
| Elevated V–ATPase Activity Following PTEN Loss Is Required for Enhanced Oncogenic Signaling in Breast Cancer AH Mohammad, SH Kim, N Bertos, W El-Assaad, I Nandi, H Smith, J Yang, ... Molecular Cancer Research 18 (10), 1477-1490, 2020 | 14 | 2020 |
| Targeting fatty acid oxidation enhances response to HER2-targeted therapy I Nandi, L Ji, HW Smith, D Avizonis, V Papavasiliou, C Lavoie, A Pacis, ... Nature Communications 15 (1), 6587, 2024 | 1 | 2024 |
| Cellular and metabolic reprogramming in breast Cancer and its therapeutic implications I Nandi McGill University (Canada), 2024 | 1 | 2024 |
| Keeping Contraceptives on the Shelf:: Family Planning in Senegal F BLackWeLL, J He, B Hodgins, G Nakhle, I Nandi, M Okano, A Qian McGill Journal of Global Health 5 (1), 34-43, 2016 | | 2016 |